New research shows teprotumumab, the only FDA-approved treatment for thyroid eye disease (TED), may lead to more frequent instances of hearing loss or muffled hearing than...
New research shows teprotumumab, the only FDA-approved treatment for thyroid eye disease (TED), may lead to more frequent instances of hearing loss or muffled hearing than...